抗微生物管理和分子诊断:一种共生方法来打击ED和ICU中的耐药性
Jan J De Waele1,2, Jerina Boelens3,4
1Department of Critical Care Medicine, Ghent University Hospital.
Current opinion in critical care
|March 25, 2024
概括
快速分子诊断 (RMD) 通过快速识别病原体,优化在急诊室和重症监护室的抗菌药物使用来增强抗菌管理计划 (ASP). 虽然RMD改善了抗菌药物决策,但它对患者结果的直接影响需要进一步调查.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 抗微生物药物耐药性需要优化抗微生物药物的使用.
- 传统的诊断可以延迟病原体的识别和适当的治疗.
- 抗微生物药物管理计划 (ASP) 对于打击耐药性至关重要.
研究的目的:
- 评估快速分子诊断 (RMD) 在ASP中的整合.
- 评估RMD在急诊室 (ED) 和重症监护室 (ICU) 管理患者中的作用.
- 要突出从传统转向RMD战略的转变,以优化抗菌药物.
主要方法:
- 对ASP中的RMD当前文献的综述.
- 分析RMD对诊断周转时间和抗菌素处方的影响.
- 评估RMD实施的挑战和促进者.
主要成果:
- 与传统方法相比,RMD为病原体识别提供了更高的准确性和更快的周转时间.
- RMD促进了更快的抗微生物决策,使治疗的适当升级或降级成为可能.
- 实施RMD可能具有挑战性,需要适应当地环境.
结论:
- 在患者管理和减少抗菌素暴露方面,RMD具有显著的价值,特别是在高耐药性环境中.
- RMD对患者结果的直接影响需要进一步研究.
- 成功将RMD整合到ED和ICU环境中,需要采用多学科方法,持续教育,并考虑当地流行病学和基础设施.
更多相关视频
12:08Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
2.7K
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
25.5K
相关概念视频
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Antimicrobial Proteins
985
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
985
